Surface Oncology Inc (SURF)

Surface Oncology (SURF) Stock Price & Analysis


SURF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.56 - $2.15
Previous Close$0.79
Average Volume (3M)207.88K
Market Cap
Enterprise Value$3.20M
Total Cash (Recent Filing)$102.06M
Total Debt (Recent Filing)$55.46M
Price to Earnings (P/E)-0.5
Aug 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding39,906,066
10 Day Avg. Volume329,372
30 Day Avg. Volume207,882
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.11
Enterprise Value/Ebitda-0.04
Price Target Upside560.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Surface Oncology Inc’s price range in the past 12 months?
Surface Oncology Inc lowest stock price was $0.56 and its highest was $2.15 in the past 12 months.
    What is Surface Oncology Inc’s market cap?
    Currently, no data Available
    When is Surface Oncology Inc’s upcoming earnings report date?
    Surface Oncology Inc’s upcoming earnings report date is Aug 15, 2023 which is in 75 days.
      How were Surface Oncology Inc’s earnings last quarter?
      Surface Oncology Inc released its earnings results on May 04, 2023. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.35 by $0.02.
        Is Surface Oncology Inc overvalued?
        According to Wall Street analysts Surface Oncology Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Surface Oncology Inc pay dividends?
          Surface Oncology Inc does not currently pay dividends.
          What is Surface Oncology Inc’s EPS estimate?
          Surface Oncology Inc’s EPS estimate is -$0.33.
            How many shares outstanding does Surface Oncology Inc have?
            Surface Oncology Inc has 60,716,873 shares outstanding.
              What happened to Surface Oncology Inc’s price movement after its last earnings report?
              Surface Oncology Inc reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.35. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Surface Oncology Inc?
                Among the largest hedge funds holding Surface Oncology Inc’s share is ARK Investment Management LLC. It holds Surface Oncology Inc’s shares valued at 4M.


                  Surface Oncology Stock Smart Score

                  The Surface Oncology stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Surface Oncology Inc

                  Surface Oncology, Inc. is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding SURF

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold SURF. The ETFs are listed according to market value of SURF within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Fate Therapeutics
                  Mirati Therapeutics
                  Ultragenyx Pharmaceutical
                  Kura Oncology

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis